Semgo Injection (Semaglutide) is an effective, once-weekly subcutaneous injection used to manage Type 2 Diabetes Mellitus (T2DM), promote sustainable weight loss, and reduce the risk of chronic kidney disease and major cardiovascular events. Available in progressive 0.25mg, 0.5mg, and 1mg pre-filled syringe doses, Semgo Injection mimics natural metabolic hormones to safely regulate long-term blood sugar, suppress appetite, and support overall cardio-renal and liver health.